Padma Sundar's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 87,500 Option to Purchase Common Stock done . Disclosure was reported to the exchange on March 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnost... | Padma Sundar | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 87,500 | 87,500 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnost... | Padma Sundar | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 87,500 | 87,500 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnost... | Padma Sundar | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 255,000 | 255,000 | - | - | Employee Stock Option (right to buy) | |
| Insight Molecular Diagnost... | Padma Sundar | SVP, Marketing & Market Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 4,177 | 4,177 (0%) | 0% | - | Common Stock |